Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mauri

Showing results (181-190 of 371) with videos related to

Pageof 38
Sort By:
Oncogene|March 12, 2020
Immune-based therapies for hepatocellular carcinomaDavid J Pinato, Nadia Guerra, Petros Fessas, et al.
Neurologia (Barcelona, Spain)|June 19, 2012
Epileptic peri-ictal psychosis, a reversible cause of psychosisC González Mingot, M P Gil Villar, D Calvo Medel, et al.
Neurologia (Barcelona, Spain)|January 26, 2015
The Spanish Society of Neurology's official clinical practice guidelines for epilepsy. Special considerations in epilepsy: comorbidities, women of childbearing age, and elderly patientsJ A Mauri Llerda, A Suller Marti, P de la Peña Mayor, et al.
Revista De Neurologia|July 23, 2011
[Predisposing factors affecting drop-out rates in preventive treatment in a series of patients with migraine]Manuel Gracia-Naya, Sonia Santos-Lasaosa, Consuelo Ríos-Gómez, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 24, 2020
Qualification of tumour mutational burden by targeted next-generation sequencing as a biomarker in hepatocellular carcinomaChing Ngar Wong, Petros Fessas, Kathy Dominy, et al.
International Journal of Cancer|June 22, 2000
p27(kip1) expression in breast carcinomas: an immunohistochemical study on 512 patients with long-term follow-upM Barbareschi, H van Tinteren, F A Mauri, et al.
Neurologia (Barcelona, Spain)|April 22, 2014
Prognosis in epilepsy: initiating long-term drug therapyJ M Mercadé Cerdá, J A Mauri Llerda, J L Becerra Cuñat, et al.
Epilepsy & Behavior : E&B|May 15, 2018
Intravenous lacosamide (LCM) in status epilepticus (SE): Weight-adjusted dose and efficacyEstevo Santamarina, Montserrat González-Cuevas, Manuel Toledo, et al.
Plos One|February 23, 2010
Endothelial cell processing and alternatively spliced transcripts of factor VIII: potential implications for coagulation cascades and pulmonary hypertensionClaire L Shovlin, Gillian Angus, Richard A Manning, et al.
Revista De Neurologia|February 25, 2012
[A study to compare independent groups of patients with episodic migraine who were treated preventively with flunarizine or nadolol]M Gracia-Naya, M Huerta-Villanueva, C Rios, et al.
Pageof 38

Showing results (181-190 of 371) with videos related to

Sort By:
Pageof 38
Oncogene|March 12, 2020
Immune-based therapies for hepatocellular carcinomaDavid J Pinato, Nadia Guerra, Petros Fessas, et al.
Neurologia (Barcelona, Spain)|June 19, 2012
Epileptic peri-ictal psychosis, a reversible cause of psychosisC González Mingot, M P Gil Villar, D Calvo Medel, et al.
Neurologia (Barcelona, Spain)|January 26, 2015
The Spanish Society of Neurology's official clinical practice guidelines for epilepsy. Special considerations in epilepsy: comorbidities, women of childbearing age, and elderly patientsJ A Mauri Llerda, A Suller Marti, P de la Peña Mayor, et al.
Revista De Neurologia|July 23, 2011
[Predisposing factors affecting drop-out rates in preventive treatment in a series of patients with migraine]Manuel Gracia-Naya, Sonia Santos-Lasaosa, Consuelo Ríos-Gómez, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 24, 2020
Qualification of tumour mutational burden by targeted next-generation sequencing as a biomarker in hepatocellular carcinomaChing Ngar Wong, Petros Fessas, Kathy Dominy, et al.
International Journal of Cancer|June 22, 2000
p27(kip1) expression in breast carcinomas: an immunohistochemical study on 512 patients with long-term follow-upM Barbareschi, H van Tinteren, F A Mauri, et al.
Neurologia (Barcelona, Spain)|April 22, 2014
Prognosis in epilepsy: initiating long-term drug therapyJ M Mercadé Cerdá, J A Mauri Llerda, J L Becerra Cuñat, et al.
Epilepsy & Behavior : E&B|May 15, 2018
Intravenous lacosamide (LCM) in status epilepticus (SE): Weight-adjusted dose and efficacyEstevo Santamarina, Montserrat González-Cuevas, Manuel Toledo, et al.
Plos One|February 23, 2010
Endothelial cell processing and alternatively spliced transcripts of factor VIII: potential implications for coagulation cascades and pulmonary hypertensionClaire L Shovlin, Gillian Angus, Richard A Manning, et al.
Revista De Neurologia|February 25, 2012
[A study to compare independent groups of patients with episodic migraine who were treated preventively with flunarizine or nadolol]M Gracia-Naya, M Huerta-Villanueva, C Rios, et al.
Pageof 38